Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Lidocaine for Postoperative Pain in Adolescent Idiopathic Scoliosis
NCT03893318Phase 4Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Jul 2019
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Opioid Consumption up to 6 weeks. Started Jul 2019; status: terminated.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03893318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03893318.